Focused initially on medical applications, particularly surgical training simulation systems, IHS has successfully developed and commercialized industry-leading Haptic and XR-based endoscopy surgical training systems for numerous hospitals and medical schools. The company has garnered partnerships with significant industry players including Shenzhen Zhichu Computer System Co., Ltd for product manufacturing, marketing, and sales, and multiple renowned research hospitals such as the Department of Gastroenterology, Beijing Tsinghua Changgung Hospital, and Vancouver General Hospital for clinical trial and evaluation platforms to facilitate product development.
Established in 2017, IHS operates within the hardware and robotics sectors. They recently secured a $1.00M Venture Round investment, with Hainan Gaojie as the primary investor, in a funding round that took place on 24 July 2023. This injection of capital is expected to facilitate the company's continued growth and further advancement of their innovative Haptic platform technology.